Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Leukemia ; 10(9): 1504-8, 1996 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-8751470

RESUMO

Serum levels of cytokines and in vitro cytokine production by lymph node mononuclear cells (LNMC) were studied in four patients with angio-immunoblastic lymphadenopathy with dysproteinemia (AILD) or AILD-type T cell lymphoma. An increased level of serum interleukin-6 (IL-6) was detected on initial diagnosis in both of two patients examined. Spontaneous production of IL-6 by LNMC was detected in all four patients studied. Immunosuppressive therapy with cyclosporin A (CsA) was attempted in a 68-year-old man, who was refractory to intensive combination chemotherapy. The increased level of IL-6 in this patient decreased to normal within 3 weeks of CsA administration and the patient became symptom-free. One and a half months later, the IL-6 level gradually increased along with clinical exacerbation. We also measured serum levels of IL-1 alpha, IL-2, IL-4, IFN-alpha, gamma and TNF-alpha in parallel with IL-6, but these factors were only sporadically detected. IL-6 production by LNMC was stimulated by IL-2 but inhibited by CsA. These observations suggest that IL-6 is one of the important cytokines to be involved in the pathophysiology of AILD and CsA is a useful reagent for relieving symptoms.


Assuntos
Transtornos das Proteínas Sanguíneas/tratamento farmacológico , Ciclosporina/uso terapêutico , Linfadenopatia Imunoblástica/tratamento farmacológico , Linfadenopatia Imunoblástica/metabolismo , Imunossupressores/uso terapêutico , Interleucina-6/biossíntese , Interleucina-6/sangue , Leucócitos Mononucleares/metabolismo , Linfonodos/citologia , Idoso , Transtornos das Proteínas Sanguíneas/sangue , Transtornos das Proteínas Sanguíneas/metabolismo , Humanos , Linfadenopatia Imunoblástica/sangue , Interleucina-6/fisiologia , Linfonodos/metabolismo , Linfoma de Células T/sangue , Linfoma de Células T/tratamento farmacológico , Linfoma de Células T/metabolismo , Masculino , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...